BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8648606)

  • 21. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
    Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
    Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.
    Bellier B; McCort-Tranchepain I; Ducos B; Danascimento S; Meudal H; Noble F; Garbay C; Roques BP
    J Med Chem; 1997 Nov; 40(24):3947-56. PubMed ID: 9397175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
    Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
    Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.
    Sagara Y; Sagara T; Uchiyama M; Otsuki S; Kimura T; Fujikawa T; Noguchi K; Ohtake N
    J Med Chem; 2006 Sep; 49(19):5653-63. PubMed ID: 16970392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of the potent peptide FK888 with unusual aminoacids: effects on activity on neurokinin receptors.
    Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Novellino E
    Farmaco; 1996 Mar; 51(3):197-201. PubMed ID: 8688142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists.
    Elliott JM; Carling RW; Chambers M; Chicchi GG; Hutson PH; Jones AB; MacLeod A; Marwood R; Meneses-Lorente G; Mezzogori E; Murray F; Rigby M; Royo I; Russell MG; Sohal B; Tsao KL; Williams B
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5748-51. PubMed ID: 16950620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the tachykinin NK3 receptor agonist senktide with behavioral effects of cocaine in marmosets (Callithrix penicillata).
    de Souza Silva MA; Mello EL; Müller CP; Jocham G; Maior RS; Huston JP; Tomaz C; Barros M
    Peptides; 2006 Sep; 27(9):2214-23. PubMed ID: 16621146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel NK(3) receptor antagonists for the treatment of schizophrenia and other CNS indications.
    Simonsen KB; Juhl K; Steiniger-Brach B; Nielsen SM
    Curr Opin Drug Discov Devel; 2010 Jul; 13(4):379-88. PubMed ID: 20597024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II.
    Elliott JM; Carling RW; Chicchi GG; Crawforth J; Hutson PH; Jones AB; Kelly S; Marwood R; Meneses-Lorente G; Mezzogori E; Murray F; Rigby M; Royo I; Russell MG; Shaw D; Sohal B; Tsao KL; Williams B
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5752-6. PubMed ID: 16950617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework.
    Giardina GA; Sarau HM; Farina C; Medhurst AD; Grugni M; Raveglia LF; Schmidt DB; Rigolio R; Luttmann M; Vecchietti V; Hay DW
    J Med Chem; 1997 Jun; 40(12):1794-807. PubMed ID: 9191956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist.
    Gerspacher M; Lewis C; Ball HA; Howes C; Subramanian N; Ryffel K; Fozard JR
    J Med Chem; 2003 Jul; 46(16):3508-13. PubMed ID: 12877589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells.
    Oury-Donat F; Carayon P; Thurneyssen O; Pailhon V; Emonds-Alt X; Soubrié P; Le Fur G
    J Pharmacol Exp Ther; 1995 Jul; 274(1):148-54. PubMed ID: 7616392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
    Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
    Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulatory effect of PG-KII, an NK3 tachykinin receptor agonist, on isolated pancreatic acini: species-related differences.
    Linari G; Improta G; Agostini S; Andreassi A; Broccardo M
    Peptides; 2004 Jan; 25(1):45-51. PubMed ID: 15003355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
    Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
    J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of activation of peripheral and spinal tachykinin neurokinin(3) receptors on the micturition reflex in rats.
    Kamo I; Chancellor MB; de Groat WC; Yoshimura N
    J Urol; 2005 Aug; 174(2):776-81. PubMed ID: 16006975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a new series of non-peptidic NK3 receptor antagonists.
    Juhl K; Hansen T; Kehler J; Khanzhin NA; Nørgaard MB; Ruhland T; Larsen DB; Jensen KG; Steiniger-Brach B; Nielsen SM; Simonsen KB
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1498-501. PubMed ID: 21292483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.